Song J, Kim S, Moon J, Jung D
Vet Med (Praha). 2024; 67(6):323-329.
PMID: 39100643
PMC: 11296221.
DOI: 10.17221/105/2020-VETMED.
Liu Y, Liu S, Zhao J, Wu K, Xu B, Wang W
Front Pharmacol. 2023; 14:1174278.
PMID: 37383707
PMC: 10299739.
DOI: 10.3389/fphar.2023.1174278.
Gupta A, Hall D, Talukder M, Bamimore M
Skin Appendage Disord. 2022; 8(5):355-361.
PMID: 36161084
PMC: 9485924.
DOI: 10.1159/000525137.
Garner B, Stolarz A, Stuckey D, Sarimollaoglu M, Liu Y, Palade P
J Pharmacol Exp Ther. 2020; 376(1):40-50.
PMID: 33100270
PMC: 7745085.
DOI: 10.1124/jpet.120.000121.
Tessadori F, Roessler H, Savelberg S, Chocron S, Kamel S, Duran K
Dis Model Mech. 2018; 11(10).
PMID: 30355756
PMC: 6215435.
DOI: 10.1242/dmm.035469.
Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process.
Burg D, Yamamoto M, Namekata M, Haklani J, Koike K, Halasz M
Clin Cosmet Investig Dermatol. 2017; 10:71-85.
PMID: 28280377
PMC: 5338843.
DOI: 10.2147/CCID.S123401.
Adenosine Triphosphate-Sensitive Potassium Currents in Heart Disease and Cardioprotection.
Nichols C
Card Electrophysiol Clin. 2016; 8(2):323-35.
PMID: 27261824
PMC: 4894346.
DOI: 10.1016/j.ccep.2016.01.005.
Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.
Mundt H, Matenaer M, Lammert A, Gottmann U, Kramer B, Birck R
J Clin Hypertens (Greenwich). 2016; 18(11):1162-1167.
PMID: 27246772
PMC: 8031757.
DOI: 10.1111/jch.12847.
Effectiveness of a Layer-by-Layer Microbubbles-Based Delivery System for Applying Minoxidil to Enhance Hair Growth.
Liao A, Lu Y, Lin Y, Chen H, Sytwu H, Wang C
Theranostics. 2016; 6(6):817-27.
PMID: 27162552
PMC: 4860890.
DOI: 10.7150/thno.14932.
The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics.
Kharade S, Nichols C, Denton J
Future Med Chem. 2016; 8(7):789-802.
PMID: 27161588
PMC: 4976861.
DOI: 10.4155/fmc-2016-0005.
FGF5 is a crucial regulator of hair length in humans.
Higgins C, Petukhova L, Harel S, Ho Y, Drill E, Shapiro L
Proc Natl Acad Sci U S A. 2014; 111(29):10648-53.
PMID: 24989505
PMC: 4115575.
DOI: 10.1073/pnas.1402862111.
KATP channels and cardiovascular disease: suddenly a syndrome.
Nichols C, Singh G, Grange D
Circ Res. 2013; 112(7):1059-72.
PMID: 23538276
PMC: 3660033.
DOI: 10.1161/CIRCRESAHA.112.300514.
Effect of Dieckol, a component of Ecklonia cava, on the promotion of hair growth.
Kang J, Kim S, Kim M, Boo H, Jeon Y, Koh Y
Int J Mol Sci. 2012; 13(5):6407-6423.
PMID: 22754373
PMC: 3382810.
DOI: 10.3390/ijms13056407.
The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results.
Sun J, Silva K, McElwee K, King Jr L, Sundberg J
Exp Dermatol. 2008; 17(10):793-805.
PMID: 18798913
PMC: 2778023.
DOI: 10.1111/j.1600-0625.2008.00773.x.
Minoxidil: a review of its pharmacological properties and therapeutic use.
Campese V
Drugs. 1981; 22(4):257-78.
PMID: 7030707
DOI: 10.2165/00003495-198122040-00001.
Comparative trial of felodipine and nifedipine in refractory hypertension.
Aberg H, Lindsjo M, Morlin B
Drugs. 1985; 29 Suppl 2:117-23.
PMID: 3886357
DOI: 10.2165/00003495-198500292-00021.
Minoxidil and captopril in severe hypertension.
Greminger P, Foerster E, Vetter H, Baumgart P, Vetter W
Klin Wochenschr. 1986; 64(7):327-32.
PMID: 3520132
DOI: 10.1007/BF01711952.
Long-term treatment of severe hypertension with minoxidil.
Nawar T, Nolin L, Plante G, Caron C, Montambault P
Can Med Assoc J. 1977; 117(10):1178-82.
PMID: 603847
PMC: 1880293.
Minoxidil in severe hypertension.
Larochelle P, Hamet P, BERONIADE V, Kuchel O
Eur J Clin Pharmacol. 1978; 14(1):1-5.
PMID: 365535
DOI: 10.1007/BF00560251.
Diuretics as initial treatment for essential hypertension.
Finnerty Jr F
Br J Clin Pharmacol. 1979; 7 Suppl 2:185S-187S.
PMID: 37873
PMC: 1429330.
DOI: 10.1111/j.1365-2125.1979.tb04689.x.